The use of cell culture medium in upstream continuous processes is costly and performing high cell density perfusion processes requires a good understanding of the process. However, when selecting a preferred supplier, it is also important to ensure business continuity from manufacturers for clinical and manufacturing processes.
This webinar discusses an overview on current industry trends in the context of intensified processes, shows the economic benefits of using a cell culture medium designed specifically for perfusion processes, and discusses risk measures suppliers need to take to facilitate business continuity and product quality.
Watch Webinar